International Stem Cell Corporation
ISCO
$0.40
$0.039.23%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 15.55% | 7.42% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.55% | 7.42% | |||
| Cost of Revenue | 27.57% | -10.51% | |||
| Gross Profit | 7.13% | 24.98% | |||
| SG&A Expenses | -12.04% | -23.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.75% | 1.50% | |||
| Operating Income | 140.00% | 39.30% | |||
| Income Before Tax | 67.73% | 36.78% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 67.73% | 36.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 67.73% | 36.78% | |||
| EBIT | 140.00% | 39.30% | |||
| EBITDA | 166.03% | 39.77% | |||
| EPS Basic | 67.64% | 36.78% | |||
| Normalized Basic EPS | 118.02% | 36.76% | |||
| EPS Diluted | 67.64% | 36.78% | |||
| Normalized Diluted EPS | 118.02% | 36.76% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||